| 名称 | 获配股数 | 占全球发售 | 占上市后总股本 | 锁定期 |
|---|---|---|---|---|
| BlackRock Funds | 0 | 3.89% | — | 6个月 |
| Cherry Tomatoes International Limited | 0 | 0.97% | — | 6个月 |
| Cormorant Asset Management, LP | 0 | 1.94% | — | 6个月 |
| CPE Greater China Enterprises Growth Fund | 0 | 1.17% | — | 6个月 |
| Fidelity International | 0 | 7.39% | — | 6个月 |
| GIC Private Limited | 0 | 1.94% | — | 6个月 |
| Hillhouse Funds | 0 | 1.94% | — | 6个月 |
| Hudson Bay Master Fund LTD | 0 | 1.94% | — | 6个月 |
| Janchor Partners Pan-Asian Master Fund | 0 | 2.33% | — | 6个月 |
| Lake Bleu Prime Healthcare Master Fund Limited | 0 | 3.89% | — | 6个月 |
| LAV Amber Limited | 0 | 3.89% | — | 6个月 |
| Matthews Asia Funds | 0 | 1.94% | — | 6个月 |
| Octagon Investments Master Fund LP | 0 | 1.55% | — | 6个月 |
| OrbiMed Funds | 0 | 2.92% | — | 6个月 |
| Vivo Funds | 0 | 1.94% | — | 6个月 |
| 加皇环球资产管理(亚洲)有限公司 | 0 | 1.36% | — | 6个月 |
| 新华资本管理有限公司 | 0 | 0.97% | — | 6个月 |
| 易方达基金管理有限公司 | 0 | 1.07% | — | 6个月 |
| 中国生物制药有限公司 | 0 | 1.17% | — | 6个月 |
本页展示 荣昌生物制药(烟台)股份有限公司 - B - H 股(09995)的打新中签分析:一手中签率、甲乙组中签分布、超额认购倍数、暗盘与首日表现。数据来自港交所配发结果公告。中签率的计算方式与回拨规则见港股中签率怎么算。

